BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11018523)

  • 1. Investigation of the molecular assembly of beta-cell K(ATP) channels.
    Mikhailov MV; Mikhailova EA; Ashcroft SJ
    FEBS Lett; 2000 Sep; 482(1-2):59-64. PubMed ID: 11018523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel.
    Mikhailov MV; Mikhailova EA; Ashcroft SJ
    FEBS Lett; 2001 Jun; 499(1-2):154-60. PubMed ID: 11418131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K(ATP) channels.
    Mikhailov MV; Ashcroft SJ
    J Biol Chem; 2000 Feb; 275(5):3360-4. PubMed ID: 10652326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships in the beta-cell K(ATP) channel.
    Mikhailov MV; Mikhailova EA; Ashcroft SJ
    Biochem Soc Trans; 2002 Apr; 30(2):323-7. PubMed ID: 12023873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
    Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
    J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K; Komine J; Matsuo M; Seino S; Amachi T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
    Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
    Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
    Hambrock A; de Oliveira Franz CB; Hiller S; Grenz A; Ackermann S; Schulze DU; Drews G; Osswald H
    J Biol Chem; 2007 Feb; 282(5):3347-56. PubMed ID: 17138562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2.
    Mukai E; Ishida H; Horie M; Noma A; Seino Y; Takano M
    Biochem Biophys Res Commun; 1998 Oct; 251(2):477-81. PubMed ID: 9792799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
    Yamada M; Kurachi Y
    J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
    Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
    Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
    Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y
    Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit.
    Gribble FM; Tucker SJ; Haug T; Ashcroft FM
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7185-90. PubMed ID: 9618560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four novel splice variants of sulfonylurea receptor 1.
    Hambrock A; Preisig-Müller R; Russ U; Piehl A; Hanley PJ; Ray J; Daut J; Quast U; Derst C
    Am J Physiol Cell Physiol; 2002 Aug; 283(2):C587-98. PubMed ID: 12107069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.